Eps Bio Technology Corp operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eps Bio Technology Corp with three other
pharmaceutical manufacturers in Asia:
Mizuho Medy Co Ltd
sales of 4.21 billion Japanese Yen [US$38.06 million]
of which 100%
was Pharmaceutical Business),
Genereach Biotechnology Corp
(857.03 million Taiwanese Dollars [US$30.83 million]
of which 69%
was Taiwan), and
New Horizon Health Ltd
based in HONG KONG
(79.49 million Hong Kong Dollars [US$10.24 million]
During the first
quarter of 2021, sales at Eps Bio Technology Corp totalled
88.48 million Taiwanese Dollars .
This is a drop of 17.3%
from the 107.05 million Taiwanese Dollars in sales at the company during the first quarter in 2020.
Eps Bio Technology Corp reported sales of 477.60 million Taiwanese Dollars (US$17.18 million)
December of 2020.
increase of 4.0%
versus 2019, when the company's sales were 459.35 million Taiwanese Dollars .